3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Carcinoma, Renal Cell
4
Carcinoma, Hepatocellular
3
Melanoma
2
Endometrial Neoplasms
2
von Hippel-Lindau Disease
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Small Cell Lung Carcinoma
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Hematologic Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Carcinoma, Transitional Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Adenoid Cystic
1
Brain Neoplasms
1
Bone Neoplasms
1
Advanced Malignancies
1
Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
1
Adenocarcinoma
1
Interventions
Letrozole
25
Fulvestrant
25
Specimen Handling
19
ribociclib
16
Capecitabine
16
pembrolizumab
14
palbociclib
14
Paclitaxel
14
Trastuzumab
13
Carboplatin
13
exemestane
12
abemaciclib
12
Tamoxifen
12
Anastrozole
12
Magnetic Resonance Spectroscopy
11
trastuzumab deruxtecan
8
pertuzumab
8
Biopsy
8
Goserelin
7
inavolisib
6
giredestrant
6
Cyclophosphamide
6
130-nm albumin-bound paclitaxel
6
patritumab deruxtecan
5
eribulin
5
elacestrant
5
Taxes
5
Standard of Care
5
Radiotherapy
5
Gonadotropin-Releasing Hormone
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
lenvatinib
×
30 days
×
Clear all
No trials found.